FDA 483 - Aurolife Pharma LLC - April 10, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Aurolife Pharma LLC, a drug product manufacturer in Durham, NC, was cited for significant deficiencies across its quality system, laboratory controls, facilities, and equipment. The inspection revealed issues with stability testing, OOS investigations, change control, environmental monitoring, equipment cleaning, pest control, calibration, and the effectiveness of corrective and preventive actions, indicating a broad lack of adherence to GMP regulations. The firm also failed to submit a Field Alert Report in a timely manner for a distributed product with device malfunctions.
ID · dab66993-8516-44fc-bf38-26f7a17f3003